Significance of serum AMH and antral follicle count discrepancy for the prediction of ovarian stimulation response in Poseidon criteria patients

被引:3
作者
Hochberg, Alyssa [1 ,2 ]
Dahan, Michael H. [1 ]
Yarali, Hakan [3 ,4 ]
Vuong, Lan N. [5 ,6 ,7 ]
Esteves, Sandro C. [8 ]
机构
[1] McGill Univ, Dept Obstet & Gynecol, 845 Rue Sherbrooke O, Montreal, PQ 3HA 0G4, Canada
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Anatolia IVF, Ankara, Turkiye
[4] Hacettepe Univ, Dept Obstet & Gynecol, Ankara, Turkiye
[5] Univ Med & Pharm Ho Chi Minh City, Dept Obstet & Gynecol, Ho Chi Minh City, Vietnam
[6] My Duc Hosp, IVFMD, Ho Chi Minh City, Vietnam
[7] My Duc Hosp, HOPE Res Ctr, Ho Chi Minh City, Vietnam
[8] ANDROFERT Androl & Human Reprod Clin, Campinas, Brazil
关键词
Ovarian stimulation; Anti-Mullerian hormone; Antral follicle count; Discordancy; Poor ovarian response; Poseidon criteria; IN-VITRO FERTILIZATION; ANTI-MULLERIAN HORMONE; HIGHLY PURIFIED HMG; RECOMBINANT FSH; ANTIMULLERIAN HORMONE; IVF; HYPERSTIMULATION; VARIABILITY; CYCLE;
D O I
10.1007/s10815-024-03050-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose To determine the risk of not being a poor responder in ovarian stimulation (OS) for in vitro fertilization (IVF) when ovarian reserve markers are discordant-one falling within Poseidon's criteria normal range (e.g., anti-M & uuml;llerian hormone (AMH) >= 1.2 ng/mL or antral follicle count (AFC) >= 5), and the other in the poor ovarian reserve range. Methods A tri-center retrospective cohort study (2015-2017) involving women with discordant AMH and AFC values undergoing their first IVF/ICSI cycle using conventional OS (cOS, >= 150 IU/day of follicle-stimulating hormone). Discordant serum AMH and AFC values were defined according to Poseidon's criteria (AMH < 1.2 ng/mL and AFC >= 5 or AMH >= 1.2 ng/mL and AFC < 5). Poor ovarian response (POR) was < 4 retrieved oocytes. Receiver operating characteristic (ROC) curves were used to determine AMH and AFC cut-offs for non-POR. Logistic regression analysis evaluated factors associated with non-POR. Results Out of 8797 patients who underwent assessment with both AMH and AFC, 1172 (13.3%) exhibited discordant values. Of these, 854 (72.9%) had >= 4 oocytes retrieved. Within this group, 726 (85.0%) had "low" AMH values, whereas 128 (15.0%) had "low" AFCs. An AFC of 6 had 77% sensitivity and 52% specificity (AUC = 0.700), while AMH of 1.19 ng/mL had 31% sensitivity and 85% specificity (AUC = 0.492) for non-POR. AFC and the use of recombinant gonadotropins were positive predictors of non-POR. Conclusions When serum AMH is < 1.19 ng/mL, but AFC is >= 6, there is a moderate likelihood of a non-POR during stimulation. Conversely, if AFC is < 5 but serum AMH is >= 1.19 ng/mL, the chances of non-POR are low. Among patients with discordant markers, AFC emerges as the primary predictor of oocyte yield.
引用
收藏
页码:717 / 726
页数:10
相关论文
共 50 条
  • [21] Combining Age, Antral Follicle Count, Anti-Mullerian Hormone, and Follicle-Stimulating Hormone Is More Accurate Than Individual Markers in Predicting Poor Ovarian Response
    Palhares Jr, Maurilio B.
    Martins, Wellington P.
    Romao, Gustavo S.
    Ferriani, Rui A.
    Navarro, Paula A.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2018, 63 (9-10) : 461 - 466
  • [22] Technical and performance characteristics of anti-Mullerian hormone and antral follicle count as biomarkers of ovarian response
    Iliodromiti, Stamatina
    Anderson, Richard A.
    Nelson, Scott M.
    HUMAN REPRODUCTION UPDATE, 2015, 21 (06) : 698 - 710
  • [23] Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Mullerian hormone versus small antral follicle count (2-6 mm)
    Aflatoonian, Abbas
    Oskouian, Homa
    Ahmadi, Shahnaz
    Oskouian, Leila
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2009, 26 (06) : 319 - 325
  • [24] Prediction of in vitro fertilization outcome at different antral follicle count thresholds combined with female age, female cause of infertility, and ovarian response in a prospective cohort of 8269 women
    Liao, ShuJie
    Xiong, Jianwu
    Tu, Haiting
    Hu, Cheng
    Pan, Wulin
    Geng, Yudi
    Pan, Wei
    Lu, Tingjuan
    Jin, Lei
    MEDICINE, 2019, 98 (41)
  • [25] Impact of body mass index and vitamin D on serum AMH levels and antral follicle count in PCOS
    Gungor, N. Dokuzeylul
    Gungor, K.
    Celik, N.
    Onal, M.
    Madenli, A. A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (01) : 179 - 187
  • [26] Predicting ovarian reserve and reproductive outcome using antimullerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure
    Bonilla-Musoles, F.
    Castillo, J. C.
    Caballero, O.
    Perez-Panades, J.
    Bonilla, F., Jr.
    Dolz, M.
    Osborne, N.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2012, 39 (01) : 13 - 18
  • [27] Predictive value of antral follicle count and serum anti-Mullerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
    Lee, Yubin
    Kim, Tae Hyung
    Park, Jae Kyun
    Eum, Jin Hee
    Lee, Hee Jun
    Kim, Jayeon
    Lyu, Sang Woo
    Kim, You Shin
    Lee, Woo Sik
    Yoon, Tae Ki
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 221 : 151 - 155
  • [28] Anti-Mullerianhormone and antral follicle count differ in their ability to predict cumulative treatment outcomes of the first complete ovarian stimulation cycle in patients fromPOSEIDONgroups 3 and 4
    Liu, Luxin
    Zhou, Canquan
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2020, 46 (09) : 1801 - 1808
  • [29] AFC vs. AMH: prediction of ovarian response in women with endometrioma undergoing controlled ovarian stimulation
    Ersahin, A. A.
    Arpaci, H.
    Ersahin, S. S.
    Celik, N.
    Acet, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (10) : 2499 - 2503
  • [30] Is assessment of anti-mullerian hormone and/or antral follicle count useful in the prediction of ovarian response in expected normal responders treated with a fixed dose of recombinant FSH and GnRH antagonists? A prospective observational study
    Ganidou, Maria A.
    Kolibianakis, Efstratios M.
    Venetis, Christos A.
    Gerou, Spiros
    Makedos, Georgios A.
    Klearchou, Nikolaos
    Tarlatzis, Basil C.
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (11) : 817 - 821